The effect of Rab27a on prognosis was only marginally significant in WHO Grade II gliomas in CGGA ( Figure 2A ) but was significant for the WHO Grade II gliomas in the Rembrandt cohort ( Figure 2D ).
← all excerpts
Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
1
—
—